Literature DB >> 26797517

A Missense Variant in TREML2 Reduces Risk of Alzheimer's Disease in a Han Chinese Population.

Teng Jiang1,2, Yu Wan3, Jun-Shan Zhou1, Meng-Shan Tan3, Qing Huang1, Xi-Chen Zhu4, Huan Lu4, Hui-Fu Wang4, Qi Chen5, Lin Tan3, Ying-Dong Zhang6, Lan Tan7,8, Jin-Tai Yu9.   

Abstract

Recently, Benitez and colleagues re-analyzed whole-exome sequencing data and revealed that a coding missense variant (rs3747742-C) in triggering receptor expressed on myeloid cells-like 2 (TREML2) gene reduced late-onset Alzheimer's disease (LOAD) risk in Caucasians. To date, no study was carried out to test this association in other ethnic groups and populations, including Han Chinese. Therefore, the aim of the current study was to validate the relation between rs3747742 and LOAD susceptibility in a large Han Chinese population including 992 LOAD patients and 1358 healthy controls. In the total sample, the minor (C) allele of rs3747742 was associated with a reduced LOAD risk under the recessive genetic model after Bonferroni correction (odds ratio (OR) = 0.713; 95 % confidence interval (CI): 0.546-0.932; P = 0.013, Bonferroni-corrected P = 0.039). Interestingly, after stratifying data according to apolipoprotein E (APOE) ε4 status, we revealed that this protection only exists in APOE ε4 carriers (recessive genetic model, OR = 0.448; 95 % CI: 0.262-0.765; P = 0.003, Bonferroni-corrected P = 0.009) in our cohort. Taken together, our findings support rs3747742-C as a protective factor for LOAD, especially in APOE ε4 carriers.

Entities:  

Keywords:  Alzheimer’s disease; Han Chinese; TREML2; Variant

Mesh:

Substances:

Year:  2016        PMID: 26797517     DOI: 10.1007/s12035-016-9706-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  26 in total

Review 1.  Novel disease-modifying therapies for Alzheimer's disease.

Authors:  Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

3.  Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.

Authors:  Elise Cuyvers; Karolien Bettens; Stéphanie Philtjens; Tim Van Langenhove; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Jasper Van Dongen; Nathalie Geerts; Githa Maes; Maria Mattheijssens; Karin Peeters; Patrick Cras; Rik Vandenberghe; Peter P De Deyn; Christine Van Broeckhoven; Marc Cruts; Kristel Sleegers
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

4.  The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk.

Authors:  Basavaraj V Hooli; Antonio R Parrado; Kristina Mullin; Wai-Ki Yip; Tian Liu; Johannes T Roehr; Dandi Qiao; Frank Jessen; Oliver Peters; Tim Becker; Alfredo Ramirez; Christoph Lange; Lars Bertram; Rudolph E Tanzi
Journal:  Neurology       Date:  2014-09-03       Impact factor: 9.910

5.  Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study.

Authors:  Josue D Gonzalez Murcia; Cameron Schmutz; Caitlin Munger; Ammon Perkes; Aaron Gustin; Michael Peterson; Mark T W Ebbert; Maria C Norton; Joann T Tschanz; Ronald G Munger; Christopher D Corcoran; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2013-07-12       Impact factor: 4.673

Review 6.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

7.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

8.  Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals.

Authors:  Jin-Tai Yu; Teng Jiang; Ying-Li Wang; Hui-Fu Wang; Wei Zhang; Nan Hu; Lin Tan; Lei Sun; Meng-Shan Tan; Xi-Chen Zhu; Lan Tan
Journal:  Neurobiol Aging       Date:  2013-10-11       Impact factor: 4.673

9.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

10.  Missense variant in TREML2 protects against Alzheimer's disease.

Authors:  Bruno A Benitez; Sheng Chih Jin; Rita Guerreiro; Rob Graham; Jenny Lord; Denise Harold; Rebecca Sims; Jean-Charles Lambert; J Raphael Gibbs; Jose Bras; Celeste Sassi; Oscar Harari; Sarah Bertelsen; Michelle K Lupton; John Powell; Celine Bellenguez; Kristelle Brown; Christopher Medway; Patrick C G Haddick; Marcel P van der Brug; Tushar Bhangale; Ward Ortmann; Tim Behrens; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Jonathan L Haines; Jim Turton; Anne Braae; Imelda Barber; Anne M Fagan; David M Holtzman; John C Morris; Julie Williams; John S K Kauwe; Philippe Amouyel; Kevin Morgan; Andy Singleton; John Hardy; Alison M Goate; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2013-12-21       Impact factor: 4.673

View more
  4 in total

1.  A TREML2 missense variant influences specific hippocampal subfield volumes in cognitively normal elderly subjects.

Authors:  Si-Yu Wang; Xiao Xue; Rui Duan; Peng-Yu Gong; Yan E; Teng Jiang; Ying-Dong Zhang
Journal:  Brain Behav       Date:  2020-02-19       Impact factor: 2.708

2.  Dysregulated expression of mRNA and SNP in pulmonary artery remodeling in ascites syndrome in broilers.

Authors:  Sufang Cheng; Xin Liu; Pei Liu; Guyue Li; Xiaoquan Guo; Guoliang Hu; Lin Li; Cong Wu; Zheng Xu; Qi Zhou; Jialin Jiang; Shixian Luo; Huajun Huang
Journal:  Poult Sci       Date:  2020-11-28       Impact factor: 3.352

3.  The Alzheimer's disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation.

Authors:  Si-Yu Wang; Xin-Xin Fu; Rui Duan; Bin Wei; Hai-Ming Cao; E Yan; Shuai-Yu Chen; Ying-Dong Zhang; Teng Jiang
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

4.  Functional insights from biophysical study of TREM2 interactions with apoE and Aβ1-42.

Authors:  Daniel L Kober; Melissa D Stuchell-Brereton; Colin E Kluender; Hunter B Dean; Michael R Strickland; Deborah F Steinberg; Samantha S Nelson; Berevan Baban; David M Holtzman; Carl Frieden; Jennifer Alexander-Brett; Erik D Roberson; Yuhua Song; Tom J Brett
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 16.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.